Pds biotech to present at the ld micro main event xvi

Princeton, n.j., sept. 26, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (pds biotech or the company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, today announced that frank bedu-addo, phd, chief executive officer of pds biotech, will present at the ld micro main event xvi being held on october 3-5, 2023, in los angeles, ca. details for the event are as follows:
PDSB Ratings Summary
PDSB Quant Ranking